Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

NCT00389077 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumors
Lymphomas

Interventions

DRUG: Perifosine

Sponsor

AEterna Zentaris